1,1'-Carbonyldiimidazole → 9-((1R,4R)-4-(tert-butyldiphenylsilyloxy)-7-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)-2-(6-fluoro-1H-benzo[d]imidazol-1-yl)-7H-purin-8(9H)-one
반응식
[Si:1]([O:18][C@H:19]1[C:28]2[C:23](=[CH:24][C:25]([F:29])=[CH:26][CH:27]=2)[C@H:22]([NH:30][C:31]2[C:36]([NH2:37])=[CH:35][N:34]=[C:33]([N:38]3[C:42]4[CH:43]=[C:44]([F:47])[CH:45]=[CH:46][C:41]=4[N:40]=[CH:39]3)[N:32]=2)[CH2:21][CH2:20]1)([C:14]([CH3:17])([CH3:16])[CH3:15])([C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C1N=CN([C:53](N2C=NC=C2)=[O:54])C=1>C1COCC1>[Si:1]([O:18][C@H:19]1[C:28]2[C:23](=[CH:24][C:25]([F:29])=[CH:26][CH:27]=2)[C@H:22]([N:30]2[C:53](=[O:54])[NH:37][C:36]3[C:31]2=[N:32][C:33]([N:38]2[C:42]4[CH:43]=[C:44]([F:47])[CH:45]=[CH:46][C:41]=4[N:40]=[CH:39]2)=[N:34][CH:35]=3)[CH2:21][CH2:20]1)([C:14]([CH3:16])([CH3:15])[CH3:17])([C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1)[C:8]1[CH:9]=[CH:10][CH:11]=[CH:12][CH:13]=1참가 물질
4
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
N4-((1R,4R)-4-(tert-butyldiphenylsilyloxy)-7-fluoro-1,2,3,4-tetrahydronaphthalen-1-yl)-2-(6-fluoro-1H-benzo[d]imidazol-1-yl)pyrimidine-4,5-diamine (490 mg, 0.751 mmol, 1 equiv) was dissolved in anhydrous THF (15 mL) and CDI (737 mg, 4.54 mmol, 7 equiv) was added. The reaction was stirred at RT under argon overnight. The solvent was removed by evaporation. The residue was dissolved in EtOAc (30 mL) and washed with saturated NaHCO3, water and brine, dried (Na2SO4). The organic layer was evaporated to dryness. The residue was applied to ISCO (12 g column, MeOH—CH2Cl2 0-2%) to give a white solid product (420 mg, 82%). MS (ESI): 673.3
후처리
- customThe solvent was removed by evaporation
- dissolutionThe residue was dissolved in EtOAc (30 mL)
- washwashed with saturated NaHCO3, water and brine
- dry with materialdried (Na2SO4)
- customThe organic layer was evaporated to dryness
출처 및 근거
- ORD 기록
- ord-e27c0e87768c4ddf841637db9f15d25f
- 출처 데이터셋
- uspto-grants-2011_02
- 특허 번호
- US07884109B2
반응 노트
불러오는 중…